Methyl 4-Bromo-2-Methoxybenzoate for Iridium Ligands: Halide Control
HPLC Purity Grades and COA Parameters for Methyl 4-bromo-2-methoxybenzoate in Iridium Ligand Synthesis
In the synthesis of iridium(III) cyclometalated complexes for OLED emitters, the purity of the organic building block Methyl 4-bromo-2-methoxybenzoate is non-negotiable. As a chemical intermediate, this compound serves as a precursor for introducing the 4-bromo-2-methoxyphenyl moiety into the cyclometalating ligand framework. At NINGBO INNO PHARMCHEM, we supply this product with typical HPLC purity exceeding 99.0%, a critical threshold for minimizing side reactions during the iridium complexation step. The Certificate of Analysis (COA) for each batch includes not only the assay but also individual impurity profiles, with special attention to the 5-bromo isomer and debrominated species. These impurities, if present above 0.5%, can lead to ligand scrambling and reduced photoluminescence quantum yields (PLQY) in the final iridium complex. For R&D managers scaling up from milligram to kilogram quantities, our high purity Methyl 4-bromo-2-methoxybenzoate ensures batch-to-batch consistency, a parameter often overlooked by generic suppliers.
| Parameter | Typical Value | Method |
|---|---|---|
| Assay (HPLC) | ≥ 99.0% | In-house HPLC-UV |
| 5-Bromo isomer | ≤ 0.3% | HPLC |
| Debrominated impurity | ≤ 0.2% | HPLC |
| Water (Karl Fischer) | ≤ 0.1% | KF titration |
| Appearance | White to off-white crystalline powder | Visual |
For those seeking a drop-in replacement for established catalog products, our material matches the specifications of major reagent brands. We have detailed a direct comparison in our article on drop-in replacement for Sigma-Aldrich 647594, where we demonstrate equivalent performance in iridium dimer formation. The manufacturing process is optimized to avoid metal catalysts that could leave trace palladium or copper residues, which are detrimental to the photophysical properties of iridium emitters. Please refer to the batch-specific COA for exact numerical specifications, as minor variations occur between production campaigns.
Trace Ortho-Bromo Migration: Impact on Steric Bulk and OLED Emitter Performance
The position of the bromine atom on the aromatic ring is not merely a structural detail; it dictates the steric and electronic environment of the resulting iridium complex. In the classic bis(2-phenylpyridine)iridium(III) acetylacetonate (Ir(ppy)₂(acac)) architecture, substituting the ppy ligand with a 4-bromo-2-methoxyphenyl group introduces both electron-donating (methoxy) and electron-withdrawing (bromo) effects. However, a less discussed but critical quality parameter is the trace migration of the bromine from the 4- to the 5-position (ortho to the ester) during the synthesis of Methyl 4-bromo-2-methoxybenzoate itself. Even 0.5% of the 5-bromo isomer can lead to the formation of iridium complexes with altered steric bulk around the metal center. This subtle change can reduce the quantum yield by up to 15% in deep-blue emitters, as the distorted geometry facilitates non-radiative decay pathways. Our quality assurance program specifically monitors this isomer by HPLC, ensuring that the 4-bromo-2-methoxybenzoic acid methyl ester used in your ligand synthesis maintains the intended steric profile. This is particularly crucial when the final iridium complex is designed for high-efficiency phosphorescent OLEDs, where the triplet ligand-centered (³LC) state energy must be precisely tuned. The π-conjugation extension through the isocyanide ancillary ligand, as explored in recent literature, further amplifies the sensitivity to positional isomerism. By controlling the bromine position, we help R&D teams avoid batch-dependent variations in emission color coordinates and excited-state lifetimes.
Non-Standard Parameter: Viscosity and Crystallization Behavior Under Sub-Zero Storage Conditions
While most suppliers report standard physical properties like melting point (typically 48–52°C for this compound), field experience reveals a non-standard parameter that impacts bulk handling: the material's tendency to form a highly viscous, semi-crystalline sludge when stored at temperatures below 5°C. This behavior is not due to simple freezing but rather a polymorphic transition that can occur in the presence of trace moisture. In our logistics operations, we have observed that Methyl 4-bromo-2-methoxybenzoate stored in unheated warehouses during winter months can develop a waxy consistency, making it difficult to discharge from drums or IBCs. This is not a purity defect—the chemical integrity remains intact—but it requires pre-heating to 25–30°C with gentle agitation before use. Our dedicated article on bulk handling and winter crystallization provides detailed protocols for IBC storage and thawing procedures. For iridium ligand synthesis, where precise stoichiometry is critical, this viscosity shift can lead to weighing errors if not addressed. We recommend that customers in cold climates request insulated packaging or schedule deliveries to coincide with immediate use. This hands-on knowledge comes from years of supplying this organic building block to chemical intermediate manufacturers and ensures that your production schedule is not disrupted by unexpected physical state changes.
Bulk Packaging and Supply Chain Reliability for Industrial-Scale Ligand Production
Scaling up iridium complex synthesis from bench to pilot plant requires a reliable supply of Methyl 4-bromo-2-methoxybenzoate in bulk quantities. NINGBO INNO PHARMCHEM offers this product in 25 kg fiber drums, 210 L steel drums, and 1000 L IBC totes, depending on the order volume and customer preference. Our manufacturing process is designed for industrial purity, with production campaigns typically yielding 500–1000 kg per batch. This scale allows us to offer competitive bulk pricing while maintaining the high purity demanded by OLED material developers. The synthesis route, starting from 2-methoxybenzoic acid via bromination and esterification, is robust and avoids the use of restricted solvents. For global manufacturers, we provide comprehensive documentation including the COA, MSDS, and a detailed manufacturing process description. While we do not claim EU REACH compliance, our packaging meets international transport standards for solid chemicals. The 210 L drums are lined with anti-static polyethylene to prevent moisture ingress, and IBCs are equipped with heating blankets upon request for cold-weather shipments. Our supply chain is backed by safety stock held in multiple warehouses, ensuring lead times of 2–3 weeks for most destinations. For custom synthesis requirements, such as deuterated analogs or specific impurity spiking for method validation, our R&D team can accommodate small-scale requests. This flexibility makes us a preferred partner for both early-stage research and commercial production of iridium-based OLED emitters.
Frequently Asked Questions
What is the minimum order quantity (MOQ) for Methyl 4-bromo-2-methoxybenzoate?
Our standard MOQ is 1 kg for sample evaluation. For bulk orders, we typically supply in 25 kg drums, but we can accommodate smaller quantities for initial trials. Contact our sales team for a tailored quotation based on your annual volume projections.
Do you provide a Certificate of Analysis (COA) with each shipment?
Yes, every batch is accompanied by a comprehensive COA that includes HPLC purity, individual impurity levels, water content, and appearance. We can also include additional tests such as residual solvents by GC or metals by ICP-MS upon request.
What is the shelf life of this product under recommended storage conditions?
When stored in a cool, dry place (15–25°C) in the original sealed container, the product is stable for at least 24 months. Retesting after this period is recommended to confirm purity before use in critical syntheses.
Can you guarantee that the 5-bromo isomer is below a certain threshold?
Our standard specification limits the 5-bromo isomer to ≤0.5%, but typical batches are below 0.3%. If your application requires a tighter limit, we can discuss custom quality control measures, including preparative HPLC purification.
Is this product suitable for use in pharmaceutical intermediates?
While our primary market is electronic materials, the high purity of our Methyl 4-bromo-2-methoxybenzoate makes it suitable as a chemical intermediate for pharmaceutical R&D. However, we do not provide DMF or other drug master files. Please evaluate the COA against your specific requirements.
Sourcing and Technical Support
Selecting a global manufacturer for Methyl 4-bromo-2-methoxybenzoate involves more than comparing bulk price lists. It requires confidence in quality assurance, understanding of the synthesis route, and the ability to troubleshoot non-standard behaviors like cold-weather crystallization. At NINGBO INNO PHARMCHEM, we combine industrial-scale production with the technical depth to support your iridium ligand development programs. Whether you need a reliable supplier for tonnage quantities or a partner for custom synthesis of related building blocks, our team is equipped to deliver. Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.